# Octapharma Plasma Inc – FDA Inspection, Feb 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d8debd98-b2e6-49a8-ba4f-4ad4f03aefd7
Source feed: FDA_Inspections

> FDA inspection 1198516 of Octapharma Plasma Inc, February 14, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198516
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-02-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1283886 - 2025-10-14
- FDA Inspection 1086459 - 2019-03-07

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nancy-l-neiger/c3209528-eeb3-4a5f-88b1-f503798ed4c5)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/94c28953-af82-44dd-8551-cdf7a9da06a8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d